查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1190904

氟化物衍生物市场 - COVID-19 的增长、趋势、影响和预测 (2023-2028)

Fluorine Derivatives Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

在 2022 年至 2027 年的预测期内，氟衍生物市场的复合年增长率预计将超过 4%。

在 COVID-19 爆发期间，人们积极寻找有效且经济的药物来降低冠状病毒疾病进展的风险。 针对 COVID-19 的氟化口服药物，包括第一种治疗 COVID-19 的口服片剂 Paxlovid，构成了一个重要的亚组。 氟化物衍生物广泛用于製药市场，可提高选择性指数、增加亲脂性、增加代谢稳定性并提高抗 COVID-19 功效。

主要亮点

  • 短期内，市场由对氟的高需求的大型工业驱动，氟比天然气更轻且更具成本效益。 此外，六氟化铀等终端用途的增加和氟化硫终端用途的增加预计将增加氟衍生物的全球消费量，从而导致市场增长。
  • 但是，据推测，由于气体释放在运输过程中存在危险，氟衍生物的需求将很快减少。 此外，製造过程的复杂性可能会阻碍新进入者，减缓市场增长，并阻碍市场扩张。
  • 但是，研发活动在氟衍生物市场的增长中发挥着关键作用。 玩家参与这些活动以发现见解和处方。 这些配方有助于增加玩家收入，在某些情况下还有助于市场增长。
  • 在预测期内，预计北美将主导全球市场。

主要市场趋势

医药行业需求旺盛

  • 4-Fluoro-3-chloroaniline 是一种有机氟化结构单元，用于合成药物和生物活性化合物。 2,6-二氟苯甲□胺是一种灰白色粉末，用作合成苯甲□尿类杀虫剂和医药化学品的重要中间体。
  • 根据世界银行数据，全球医药製造业结构高度集中，美国企业相对较少，欧洲国家企业较少，印度和中国企业较少。
  • 阿斯利康表示，在需求大幅增长的推动下，2021 年 Covid 疫苗的销售额将达到 1.186 万亿美元，与 2020 年的 11.01 亿美元相比增长近 8%。
  • 美国的医疗保健和製药行业是全球市场中最先进的行业之一。 根据医疗保险和医疗补助服务中心的数据，美国医疗保健支出在 2020 年增长了 9.7%，达到 4.1 万亿美元。 医疗保健支出约占该国 GDP 的 19.7%。
  • 该国人均医疗费用的增加、医疗基础设施的进步、保险政策的普及以及传染病和慢性病的增加导致多次住院并获得各种医疗服务和药物。现在 为此，製药应用□□对氟衍生物的需求也在增加。

北美主导市场

  • 北美在市场份额和市场收入方面主导着氟衍生物市场。 该地区将在预测期内继续发挥其主导地位。
  • 氟衍生物在製药和核燃料行业的使用增加将推动市场增长。
  • 不断增长的医疗保健支出、政府对消费者整体健康的关注以及技术进步是推动北美氟衍生物市场规模增长的主要因素。
  • 北美最大的医药市场是美国。 美国约占全球医药市场的 45% 和全球产量的约 22%。 由于免疫接种实践以及对基本和非基本治疗的需求增加，美国的药品销售和生产一直很强劲。
  • 这些因素正在推动市场增长。

竞争格局

氟衍生物市场是一个综合性市场。 市场上的主要製造商包括 Thermo Fisher、VIO CHEMICALS、NINGBO INNO PHARMCHEM、Alchem Synthon Pvt, Ltd、石家庄 Old Bridge Chemicals Co. 等。

其他福利。

  • Excel 格式的市场预测 (ME) 表
  • 三个月的分析师支持

内容

第一章介绍

  • 调查先决条件
  • 调查范围

第二章研究方法论

第 3 章执行摘要

第四章市场动态

  • 司机
    • 六氟化铀等氟衍生物的最终用户增加
    • 增加氟化硫的最终用途
  • 约束因素
    • 运输过程中的危险
    • 复杂的製造过程阻碍了新进入者
  • 工业价值链分析
  • 波特的五力分析
    • 供应商的议价能力
    • 消费者的议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争程度

第 5 章市场细分

  • 导数
    • 3-氯-4-氟苯胺
    • 2,4-二氟芐胺
    • 2,6-二氟苯甲□胺
    • 2,4-二氟苯胺
    • 其他衍生物
  • 用法
    • 医药
    • 有机合成
    • 杀虫剂
    • 其他用途
  • 按地区
    • 亚太地区
      • 中国
      • 印度
      • 日本
      • 韩国
      • 其他亚太地区
    • 北美
      • 美国
      • 加拿大
      • 墨西哥
    • 欧洲
      • 德国
      • 英国
      • 法国
      • 意大利
      • 西班牙
      • 其他欧洲
    • 南美洲
      • 巴西
      • 阿根廷
      • 其他南美洲
    • 中东和非洲
      • 沙特阿拉伯
      • 南非
      • 其他中东和非洲地区

第六章竞争格局

  • 併购、合资企业、联盟、合同
  • 市场份额 (%)**/排名分析
  • 主要参与者采用的策略
  • 公司简介
    • Aarti Industries
    • Alchem Synthon Pvt. Ltd
    • Gujarat Fluorochemicals Limited（GFL）
    • Krishna Solvechem Ltd
    • Kingchem Life Science LLC
    • Merck KGaA
    • NINGBO INNO PHARMCHEM
    • Shijiazhuang Old Bridge Chemicals Co.
    • Thermo Fisher
    • VIO CHEMICALS

第七章市场机会与未来趋势

  • 研发活动将在氟衍生物市场的发展中发挥重要作用
简介目录
Product Code: 92721

The fluorine derivatives market is expected to register a CAGR of over 4% during the forecast period of 2022-2027.

During the outbreak of COVID-19, the search for effective and economical drugs that would reduce the risk of progression of the coronavirus disease became abundantly clear. Fluorinated oral drugs against COVID-19, including Paxlovid, the first oral tablet to treat COVID-19, form an important subgroup. Fluorine derivatives are widely used in the pharmaceutical market and can lead to improved selectivity indices, increased lipophilicity, greater metabolic stability, and improved anti-COVID-19 efficacy.

Key Highlights

  • Over the short term, the market is driven by large industries as they have a high demand for fluorine, which is light and more cost-effective than gas. Furthermore, increasing end-users such as uranium hexafluoride and increasing end-use of sulfur fluoride are expected to increase the global consumption of fluorine derivatives, leading to market growth.
  • However, it is estimated that the demand for fluorine derivatives will decrease shortly due to the harmful hazardous effects during transportation if the gas is released. In addition, the complex manufacturing process discourages the entry of new entrants and is likely to slow down market growth and prevent market expansion.
  • Nevertheless, research and development activities play a significant role in the growth of the fluorine derivatives market. Players are engaged in these activities to discover insights and formulations. These formulations help increase the players' revenue and possibly contribute to market growth.
  • North America is expected to dominate the global market during the forecast period.

Key Market Trends

Booming Demand from the Pharmaceutical Segment

  • 4-Fluoro-3-chloroaniline is an organic fluorinated building block used to synthesize pharmaceutical and biologically active compounds. 2,6-Difluorobenzamide is an off-white powder used as an essential intermediate in synthesizing benzoylurea insecticides and pharmaceutical chemicals.
  • As per the World Bank data, the structure of the global pharmaceutical manufacturing industry is highly concentrated, with relatively few firms in United States, a handful in European countries, and a lesser extent in India and China.
  • According to AstraZeneca, covid vaccine sales in 2021 were USD 1,186 billion, an increase of almost 8% compared to the total of USD 1,101 billion in 2020, indicating a significant increase in demand.
  • The healthcare and pharmaceutical sector in United States is one of the most advanced sectors in the global market. According to the Centers for Medicare & Medicaid Services, the nation's healthcare spending grew 9.7% in 2020 to USD 4.1 trillion. Healthcare spending accounted for around 19.7% of the country's GDP.​
  • An increase in per capita health care expenditure, advancement in health infrastructure, availability of insurance policies, and increase in the number of infectious and chronic diseases in the country have led to the hospitalization of several patients and the use of various medical services and pharmaceutical drugs. This has also increased the demand for fluorine derivatives in pharmaceutical applications.​

North America Region to Dominate the Market

  • North America dominates the fluorine derivatives market in terms of market share and market revenue. The region is set to continue to flourish in its dominance over the forecast period.
  • The increasing use of fluorine derivatives in the pharmaceutical and nuclear fuels industries shall drive market growth.
  • The rise in healthcare expenditure, government focus on consumers' overall health, and technological advancement are the key factors driving the North American fluorine derivatives market size.
  • United States has the largest pharmaceutical market in North America. The country accounts for around 45% of the global pharmaceutical market and around 22% of global production. United States pharmaceutical sales and output remain robust due to the ongoing vaccinations and ramp-up demand for essential and non-essential medical treatments.
  • All the attributes mentioned above are likely to drive market growth.

Competitive Landscape

The fluorine derivatives market is consolidated in nature. Some of the major manufacturers in the market include Thermo Fisher, VIO CHEMICALS, NINGBO INNO PHARMCHEM, Alchem Synthon Pvt, Ltd., Shijiazhuang Old Bridge Chemicals Co., and others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Drivers
    • 4.1.1 Increasing End-Users of Fluorine Derivatives such as Uranium Hexafluoride
    • 4.1.2 Increasing End-Use of Sulfur Fluoride
  • 4.2 Restraints
    • 4.2.1 Hazardous Effects During Transportation
    • 4.2.2 Complex Manufacturing Process Discourages the Entry of New Entrants
  • 4.3 Industry Value-Chain Analysis
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Bargaining Power of Suppliers
    • 4.4.2 Bargaining Power of Consumers
    • 4.4.3 Threat of New Entrants
    • 4.4.4 Threat of Substitute Products and Services
    • 4.4.5 Degree of Competition

5 MARKET SEGMENTATION

  • 5.1 Derivatives
    • 5.1.1 3-Chloro-4-Flouro Aniline
    • 5.1.2 2,4-Diflouro Benzylamine
    • 5.1.3 2,6-Diflouro Benzamide
    • 5.1.4 2,4-Difluoro Aniline
    • 5.1.5 Other Derivatives
  • 5.2 Applications
    • 5.2.1 Pharmaceutical
    • 5.2.2 Organic Synthesis
    • 5.2.3 Agrochemicals
    • 5.2.4 Other Applications
  • 5.3 Geography
    • 5.3.1 Asia-Pacific
      • 5.3.1.1 China
      • 5.3.1.2 India
      • 5.3.1.3 Japan
      • 5.3.1.4 South Korea
      • 5.3.1.5 Rest of Asia-Pacific
    • 5.3.2 North America
      • 5.3.2.1 United States
      • 5.3.2.2 Canada
      • 5.3.2.3 Mexico
    • 5.3.3 Europe
      • 5.3.3.1 Germany
      • 5.3.3.2 United Kingdom
      • 5.3.3.3 France
      • 5.3.3.4 Italy
      • 5.3.3.5 Spain
      • 5.3.3.6 Rest of Europe
    • 5.3.4 South America
      • 5.3.4.1 Brazil
      • 5.3.4.2 Argentina
      • 5.3.4.3 Rest of South America
    • 5.3.5 Middle-East and Africa
      • 5.3.5.1 Saudi Arabia
      • 5.3.5.2 South Africa
      • 5.3.5.3 Rest of Middle-East and Africa

6 COMPETITIVE LANDSCAPE

  • 6.1 Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
  • 6.2 Market Share(%)**/Ranking Analysis**
  • 6.3 Strategies Adopted by Leading Players
  • 6.4 Company Profiles
    • 6.4.1 Aarti Industries
    • 6.4.2 Alchem Synthon Pvt. Ltd
    • 6.4.3 Gujarat Fluorochemicals Limited (GFL)
    • 6.4.4 Krishna Solvechem Ltd
    • 6.4.5 Kingchem Life Science LLC
    • 6.4.6 Merck KGaA
    • 6.4.7 NINGBO INNO PHARMCHEM
    • 6.4.8 Shijiazhuang Old Bridge Chemicals Co.
    • 6.4.9 Thermo Fisher
    • 6.4.10 VIO CHEMICALS

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

  • 7.1 Research and Development Activities play a Significant Role in the Growth of the Fluorine Derivatives Market